Rare diseases
Investigational molecules
Locations
400 Somerset Corporate Boulevard, 08807-2867, United States
Clinical research focuses on overt hepatic encephalopathy and the prevention of encephalopathy-related deterioration in people with cirrhosis. The sponsored studies address treatment areas linked to HE-related hospitalization and delayed decompensation.
These investigations reflect a therapeutic interest in liver-related neurocognitive complications and their clinical consequences.
Salix Pharmaceuticals Inc. runs clinical trials in conditions such as Hepatic encephalopathy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
